Risk Factors for Reoperation After Photoselective Vaporization of the Prostate Using a 120 W GreenLight High Performance System Laser for the Treatment of Benign Prostatic Hyperplasia

被引:7
|
作者
Kim, Kang Sup [1 ]
Choi, Jin Bong [1 ]
Bae, Woong Jin [1 ,2 ]
Kim, Su Jin [1 ]
Cho, Hyuk Jin [1 ]
Hong, Sung-Hoo [1 ]
Lee, Ji Youl [1 ]
Kim, Sae Woong [1 ,2 ]
Han, Dong-Seok [1 ]
机构
[1] Catholic Univ Korea, Dept Urol, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Catholic Integrat Med Res Inst, Coll Med, Seoul, South Korea
关键词
URINARY-TRACT SYMPTOMS; MONOPOLAR TRANSURETHRAL RESECTION; RANDOMIZED CLINICAL-TRIAL; SINGLE-CENTER EXPERIENCE; TITANYL-PHOSPHATE LASER; FOLLOW-UP; EAU GUIDELINES; EVENT ANALYSIS; MANAGEMENT; COMPLICATIONS;
D O I
10.1089/pho.2015.4050
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: We investigated risk factors in a large cohort of patients who underwent reoperation after photoselective vaporization of the prostate using the 120 W GreenLight High Performance System laser for treatment of benign prostatic hyperplasia. Background data: Complications such as recurrent/residual adenoma, urethral stricture, or bladder neck might occur after photoselective vaporization of the prostate for treatment of benign prostatic hyperplasia. Materials and methods: We reviewed the data of 1040 patients who underwent photoselective vaporization of the prostate between April 2009 and December 2014, and analyzed the clinical data of 630 patients who completed >12 months of follow-up. Patients were evaluated for perioperative and late complications. Reoperation was defined as the necessity for any surgical intervention to resolve recurrent/residual adenoma, urethral stricture, or bladder neck contracture. Patients with recurrent/residual adenoma, urethral stricture, or bladder neck contracture were compared with those without complications to identify the risk factors for reoperation. Logistic regression analysis was conducted to estimate the risk of reoperation. Results: Reoperation was performed in 25 of 630 patients (3.9%) at 35.5 months mean follow-up: 12 had recurrent/residual adenoma, 5 had urethral stricture, and 8 had bladder neck contracture. Multivariate analysis revealed that a higher prostate-specific antigen (PSA) (OR, 1.129; p=0.023) and longer lasing time (OR, 0.883; p=0.024) were predictors of recurrent/residual adenoma. Urethral stricture was associated with a history of transurethral surgery (OR, 1.321; p=0.042). Preoperative small prostate volume was a risk factor for bladder neck contracture (OR, 0.901; p=0.011). Conclusions: In our study, the significant factors related to recurrent/residual adenoma were a high preoperative PSA and longer lasing time. A history of transurethral surgery was significantly associated with urethral stricture, whereas preoperative small prostate volume was significantly associated with bladder neck contracture.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 50 条
  • [1] 120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Detrusor Underactivity
    Choi, Sae Woong
    Choi, Yong Sun
    Bae, Woong Jin
    Kim, Su Jin
    Cho, Hyuk Jin
    Hong, Sung Hoo
    Lee, Ji Youl
    Hwang, Tae Kon
    Kim, Sae Woong
    [J]. KOREAN JOURNAL OF UROLOGY, 2011, 52 (12) : 824 - 828
  • [2] 120-W GreenLight Laser Photoselective Vaporization of Prostate for Benign Prostatic Hyperplasia: Midterm Outcomes REPLY
    Tasci, Ali Ihsan
    Sahin, Selcuk
    Tugcu, Volkan
    Ilbey, Yusuf Ozlem
    Luleci, Huseyin
    Cicekler, Olcay
    Cevik, Cem
    [J]. UROLOGY, 2011, 78 (01) : 141 - 141
  • [3] 120-W GreenLight Laser Photoselective Vaporization of Prostate for Benign Prostatic Hyperplasia: Midterm Outcomes COMMENT
    Lingeman, James E.
    [J]. UROLOGY, 2011, 78 (01) : 140 - 141
  • [5] Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia
    Fu, WJ
    Hong, BF
    Wang, XX
    Yang, Y
    Cai, W
    Gao, JP
    Chen, YF
    Zhang, CE
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2006, 8 (03) : 367 - 371
  • [6] Photoselective vaporization of the prostate with Greenlight HPS 120 W laser in patients with benign prostatic hyperplasia - results of treatment of first 100 consecutive patients
    Zielinski, H.
    Piotrowicz, G.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 577 - 578
  • [7] Photoselective Vaporization of the Prostate with GreenLight HPS 120-W Laser for Benign Prostatic Hyperplasia: 36 Months' Follow-Up
    Zang, Yachen
    Xue, Boxin
    Zhang, Yuanyuan
    Yang, Dongrong
    Gao, Jie
    Sun, Chuanyang
    Cui, Yong
    Tao, Wei
    Chen, Dong
    Shan, Yuxi
    [J]. UROLOGIA INTERNATIONALIS, 2012, 89 (02) : 203 - 207
  • [8] Effectiveness and Safety of Photoselective Vaporization of the Prostate with the 120 W HPS Greenlight Laser in Benign Prostatic Hyperplasia Patients Taking Oral Anticoagulants
    Sohn, Jun Ho
    Choi, Yong Sun
    Kim, Su Jin
    Cho, Hyuk Jin
    Hong, Sung Hoo
    Lee, Ji Youl
    Hwang, Tae-Kon
    Kim, Sae Woong
    [J]. KOREAN JOURNAL OF UROLOGY, 2011, 52 (03) : 178 - 183
  • [9] Long-Term Follow-Up Results of Photoselective Vaporization of the Prostate with the 120 W Greenlight HPS Laser for Treatment of Benign Prostatic Hyperplasia
    Kang, Se-Hee
    Choi, Yong Sun
    Kim, Su Jin
    Cho, Hyuk Jin
    Hong, Sung-Hoo
    Lee, Ji Youl
    Hwang, Tae-Kon
    Kim, Sae Woong
    [J]. KOREAN JOURNAL OF UROLOGY, 2011, 52 (04) : 260 - 264
  • [10] Comparison of Penile Cuff Test and Conventional Urodynamic Study Prior to Photoselective Vaporization of Prostate for Benign Prostate Hyperplasia Using a 120 W GreenLight High Performance System Laser
    Kim, Kang Sup
    Choi, Yong Sun
    Bae, Woong Jin
    Cho, Hyuk Jin
    Lee, Ji Youl
    Hong, Sung-Hoo
    Kim, Sae Woong
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)